ABSTRACT
More than 1 million percutaneous coronary interventions (PCIs) are performed annually in the United States with an estimated 36% performed in women, and approximately 4550% using intracoronary stents and more recently drug-eluting stents.1 This chapter will review our current understanding of gender-based referral patterns for PCI, as well as the risks and outcomes associated with coronary interventions in women according to specific interventional devices and the presenting clinical syndromes. This is in accordance with the recently published American Heart Association Consensus Statement on percutaneous coronary intervention and adjunctive pharmacotherapy in women.2
